CLEVELAND, Ohio, Aug. 30 [Category: BizHospital] -- The Cleveland Clinic posted the following news release: * * * Cleveland Clinic-Led Trials Shows Drug Doesn't Significantly Improve Outcomes in Patients with Non-Obstructive Hypertrophic Cardiomyopathy * Findings from a Cleveland Clinic -led clinical trial showed that the use of the drug, mavacamten in symptomatic, non-obstructive hypertrophic cardiomyopathy patients did not significantly reduce symptoms compared to placebo. Results from t more PR

SOPHIA ANTIPOLIS, France, Aug. 30 -- The European Society of Cardiology issued the following news release: * * * Aficamten is superior to metoprolol for symptomatic obstructive hypertrophic cardiomyopathy * Beta-blockers are commonly used in the initial treatment of symptomatic obstructive hypertrophic cardiomyopathy (HCM), despite limited evidence of their efficacy. * The MAPLE-HCM trial compared the cardiac myosin inhibitor, aficamten, with the beta-blocker, metoprolol, as monotherapy, in more PR

SOPHIA ANTIPOLIS, France, Aug. 30 -- The European Society of Cardiology issued the following news release: * * * Beta-blockers did not reduce cardiovascular events in selected heart attack patients in the REBOOT trial * While beta-blockers are a foundational treatment after acute myocardial infarction (MI) in patients with reduced left ventricular ejection fraction (LVEF), their role in patients with mildly reduced or preserved LVEF (>40%) is less certain. * The REBOOT trial demonstrated a  more PR

SOPHIA ANTIPOLIS, France, Aug. 30 -- The European Society of Cardiology issued the following news release: * * * Beta-blockers reduced cardiovascular events in selected heart attack patients without heart failure in the BETAMI-DANBLOCK trials * While beta-blockers are strongly recommended for patients with myocardial infarction (MI) and reduced left ventricular ejection fraction (LVEF), their role in patients with preserved or mildly reduced LVEF (40%) is less certain. * The BETAMI-DANBLOCK more PR

SOPHIA ANTIPOLIS, France, Aug. 30 -- The European Society of Cardiology issued the following news release: * * * No improvements with mavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy * There are currently no approved therapies for nonobstructive hypertrophic cardiomyopathy (HCM). * The ODYSSEY-HCM trial compared the cardiac myosin inhibitor, mavacamten, with placebo in patients with symptomatic nonobstructive HCM. * Mavacamten was not associated with significant improv more PR

SOPHIA ANTIPOLIS, France, Aug. 30 -- The European Society of Cardiology issued the following news release: * * * Olezarsen reduces levels of the blood fat, triglycerides, in patients at high cardiovascular risk * An unmet need exists for effective therapies to lower triglyceride levels in patients with residual cardiovascular risk despite optimal lipid-lowering therapies. * The ESSENCE-TIMI 73b trial investigated the efficacy and safety of the apolipoprotein C-III RNA-targeting medicine, ol more PR

GOSHEN, Indiana, Aug. 30 -- Goshen College issued the following news: * * * Goshen College announces 2025-26 lecture series Goshen College will host five lectures in its 2025-26 lecture series, as part of its ongoing effort to bring a wide variety of speakers to campus. The series includes two lectures in the fall semester and three in the spring, all of which will be livestreamed and free and open to the public. * * * Fall Semester Beechy Peace, Justice and Reconciliation Lecture Wednesd more PR

BRISTOL, Rhode Island, Aug. 30 (TNSjou) -- Roger Williams University issued the following news: * * * From Prague to Publication: How One Public Relations Major Redefined Celebrity Cooper Hughes shows what is possible through RWU's distinctive approach to education, combining mentorship, global learning, and real-world impact. By Mikayla Larguinha What began as a casual conversation abroad led to a published paper, an academic conference in Athens, and a lasting legacy at Roger Williams Uni more PR

LA JOLLA, California, Aug. 30 (TNSjou) -- The Salk Institute for Biological Studies issued the following news release: * * * All DRII-ed up: How do plants recover after drought? Salk Institute researchers find plants rapidly boost their immune systems during drought recovery, pinpointing potential genetic strategies for designing more drought-resistant crops * A plant's number one priority is to grow--a feat that demands sunlight, nutrients, and water. If just one of these three inputs is m more PR

LA JOLLA, California, Aug. 30 (TNSjou) -- The Salk Institute for Biological Studies issued the following news release: * * * Leveraging microproteins to treat obesity, aging, and mitochondrial disorders Salk Institute researchers discover new microprotein that controls metabolic health in mouse fat cells * Like bees breathing life into gardens, providing pollen and making flowers blossom, little cellular machines called mitochondria breathe life into our bodies, buzzing with energy as they  more PR

LONDON, England, Aug. 30 (TNSjou) -- The University College London issued the following news: * * * Promising new drug for people with stubborn high blood pressure A new treatment has been shown to significantly lower blood pressure in people whose levels stay dangerously high, despite taking several existing medicines, according to the results of a Phase III clinical trial led by a UCL Professor. * Globally around 1.3 billion people have high blood pressure (hypertension), and in around ha more PR

LAWRENCE, Kansas, Aug. 30 (TNSjou) -- The University of Kansas issued the following news: * * * Spanish celebrity couple from last century embraced power of myth Think for a moment of the relationship between Arthur Miller and Marilyn Monroe -- he a celebrated playwright and she a younger actress. That's the rough equivalent of the union between Spain's Raquel Meller and Enrique Gomez Carrillo in the early 20th century. The sparks of synergy -- and conflict -- generated by the (mis)match of  more PR

NOTRE DAME, Indiana, Aug. 30 (TNSjou) -- The University of Notre Dame posted the following news: * * * 'Prebunking' false election claims may boost trust in elections By Christine Grashorn In recent years, democracies worldwide have seen a growing erosion of trust in election outcomes and institutions, driven in part by fears of widespread fraud. As the digital age continues to transform the ways in which people consume information, online election misinformation has expanded at an unpreced more PR

LOGAN, Utah, Aug. 30 -- Utah State University issued the following news: * * * ASPIRE REU Program: Expanding the Call for Undergraduate Researchers By Kayleigh Kearsley Every summer, ASPIRE hosts the Research Experience for Undergraduates program, where students from across the nation are invited to apply to be paired with an ASPIRE faculty member and conduct research for two months during the summer. "Through the REU program, more motivated undergraduate students outside ASPIRE campuses ca more PR

NEW HAVEN, Connecticut, Aug. 30 (TNSjou) -- Yale University issued the following news release: * * * Yale Study: Potential Treatment Pathway Found for Rare and Aggressive Leukemia Tackling RNA Tagging and Wnt Signaling in Acute Megakaryoblastic Leukemia By Naedine Hazell A Yale study published Aug. 28 on the cover of the journal Blood explains basic scientific discoveries that could lead to innovative therapies for acute myeloid leukemia, and specifically a rare and aggressive blood cancer  more PR

NEW HAVEN, Connecticut, Aug. 30 (TNSjou) -- Yale University issued the following news release: * * * Study: Sex-selective abortion bans harm maternal and infant health A new study by Yale sociologist Emma Zang links sex-selective abortion bans to negative birth outcomes for Asian immigrant mothers. By Mike Cummings Sex-selective abortion bans (SSABs) -- which prohibit the seeking of abortions based on the fetus' sex -- increase the likelihood of low birth weight and preterm births among in more PR